Foundational AI Model

Business

Moonshot AI's Latest Model Claims Edge Over U.S. Rivals as China's Tech Giants Secure Critical Nvidia Chips

Alibaba-backed Moonshot AI has unveiled an upgraded flagship model, Kimi K2.5, asserting superiority in video generation and agentic capabilities against leading U.S. models. The development coincides with Beijing's approval for major tech firms, including Alibaba, to import advanced Nvidia H200 AI chips, signaling a dual-track strategy in the intensifying global AI race.

Jan 30, 2026

Business

Nvidia Aided China's DeepSeek In Advancing Powerful AI Models Later Linked To Military Use, House Committee Chair Alleges: Report

A U.S. lawmaker has alleged that Nvidia Corp (NASDAQ:NVDA) provided technical assistance to Chinese AI startup DeepSeek. Nvidia Technical Support Allegedly Boosted DeepSeek's Efficiency Nvidia helped DeepSeek improve the efficiency of its artificial intelligence models, according to a letter sent to the U.S. Commerce Department by Rep. John Moolenaar (R-Mich.), chair of the House Select Committee on China. The letter, seen by Reuters on Wednesday, says documents obtained by the committee show th

Jan 30, 2026

Business

Japan Bets Big on AI Sovereignty with $6.3 Billion Public-Private Push

In a strategic move to reduce reliance on foreign tech giants, Japan launches a national AI initiative, combining SoftBank's leadership with substantial government backing to develop a domestic foundational model.

Jan 30, 2026

Business

Apple's Valuation Crossroads: Is the Tech Giant Overpriced or a Hidden Bargain?

As Apple's stock experiences recent volatility, investors are grappling with a critical question: does its current price reflect its long-term potential? A deep dive into valuation models reveals a complex picture, with traditional metrics painting conflicting signals about the iPhone maker's true worth.

Feb 2, 2026

Business

GitLab's AI Ambitions: Can a Beleaguered Stock Stage a 2026 Comeback?

After two punishing years, GitLab's shares have been battered by fears over AI's impact on coding. But with a strategic pivot to an AI-powered development platform and a resilient business model, 2026 could be the year the company turns the narrative around.

Jan 31, 2026

Business

Beyond the Scalpel: How Intuitive Surgical and Medtronic Are Positioning for the AI-Driven Future of Surgery

While fully autonomous robotic surgeons remain on the horizon, the foundational technology and data ecosystems being built today are setting the stage for a transformative shift. Two industry giants, Intuitive Surgical and Medtronic, offer investors distinct pathways to capitalize on this evolving landscape.

Jan 30, 2026

Business

Google's 'Project Genie' AI Shakes Gaming Industry, Sends Stocks Tumbling

Shares of major video game companies plunged Friday after Google unveiled a groundbreaking AI model capable of generating interactive worlds from simple prompts, sparking investor fears of industry disruption.

Jan 30, 2026

Business

Eastern Bankshares: A Valuation Puzzle Amid Strong Share Price Gains

Eastern Bankshares (EBC) has delivered impressive multi-year returns for shareholders, but a closer look reveals a complex valuation picture. While one model suggests deep undervaluation, traditional metrics paint a different story, leaving investors to weigh competing signals.

Feb 2, 2026

Business

Tyson Foods Stock Surges: Is the Meat Giant Still a Bargain at $65?

Tyson Foods shares have rallied over 12% this year, pushing its price toward $65. But a deep dive into valuation metrics reveals a complex picture: while a cash flow model suggests significant upside, its lofty P/E ratio tells a cautionary tale. Investors are left weighing growth expectations against current premiums.

Feb 2, 2026

Business

Saint-Gobain Shares Dip: A Buying Opportunity or Fairly Valued?

Recent share price weakness at French construction giant Compagnie de Saint-Gobain has investors questioning its valuation. While a key model suggests the stock is fairly priced, its low P/E ratio compared to peers hints at potential undervaluation, setting the stage for a nuanced debate on the stock's true worth.

Feb 2, 2026

Business

Exelixis Stock: A Biotech Winner's Valuation Puzzle After Years of Stellar Gains

Exelixis shares have delivered impressive multi-year returns, but recent price weakness has investors questioning if the rally has run its course. A deep dive into valuation models suggests the stock may still be significantly undervalued, presenting a potential opportunity amidst market uncertainty.

Feb 2, 2026

Business

Micron's AI Rally: Is the Memory Chip Giant Still a Buy After Soaring 119%?

Micron Technology's stock has skyrocketed over 360% in the past year, fueled by insatiable AI-driven demand for memory chips. But with shares now trading at a significant premium to some traditional valuation models, investors face a critical question: has the rally run too far, too fast?

Feb 2, 2026

Business

Beyond the AI Hype: How CrowdStrike's Cybersecurity Network Thrives in the New Threat Landscape

While investors chase pure-play AI stocks, cybersecurity leader CrowdStrike demonstrates how leveraging AI defensively within a robust platform model can drive sustained, profitable growth amid escalating digital threats.

Feb 2, 2026

Business

Avolta AG Valuation Analysis: Is the Travel Retail Giant Trading at Fair Value?

A deep-dive valuation using a Discounted Cash Flow model suggests Avolta AG's shares are trading close to their intrinsic fair value. We break down the assumptions, the numbers, and the critical factors investors should consider beyond the model.

Feb 2, 2026

Business

BeOne Medicines Doubles Down on Predictive Modeling in Expanded InSysBio Alliance

BeOne Medicines (NasdaqGS: ONC) has significantly expanded its strategic partnership with systems biology firm InSysBio. The deepened collaboration aims to leverage advanced mechanistic modeling to de-risk clinical trial design, with a particular focus on optimizing dosing and preempting safety challenges like cytokine release syndrome in oncology studies.

Feb 2, 2026

Business

Tesla's Valuation Crossroads: Short-Term Gains Clash With Long-Term Ambitions

Tesla's stock is navigating turbulent waters, with a recent one-day surge contrasting sharply against a weaker quarterly performance. As the EV pioneer's share price hovers above some analyst targets, investors are left weighing its ambitious robotaxi and AI-driven future against more conservative valuation models.

Feb 2, 2026

Business

AstraZeneca's Valuation Puzzle: Strong Pipeline and Steady Gains Mask Undervalued Opportunity?

Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.

Jan 31, 2026

Business

Amid Steep Decline, $24 Million Bet Highlights Faith in FactSet's Enduring Data Model

As FactSet's stock price fell 45% over the past year, investment firm McDonald Capital Investors made a significant $24 million purchase, underscoring a long-term conviction in the financial data provider's resilient, high-margin subscription business.

Jan 30, 2026

Business

FTAI Aviation Soars: Can the High-Flying Stock Maintain Altitude After 167% Rally?

FTAI Aviation Ltd. has captivated investors with a staggering 167% surge, driven by explosive revenue growth and a unique hybrid model. But with a sky-high valuation, the market debates whether this aviation equipment leader is poised for a smooth cruise or facing turbulent air ahead.

Jan 30, 2026

Business

JPMorgan Adjusts Edison International Outlook Ahead of Q4 Earnings, Maintains Neutral Stance

JPMorgan raises Edison International's price target to $66, citing model updates ahead of earnings. The utility giant, noted for its sustainable high-yield dividend, continues to benefit from California's electrification trends and regulated investment framework.

Jan 30, 2026